1. Synergistic enhancement: Exploring the potential of piperine in cancer therapeutics through chemosensitization and combination therapies.
- Author
-
Manickasamy MK, Kumar A, BharathwajChetty B, Alqahtani MS, Abbas M, Alqahtani A, Unnikrishnan J, Bishayee A, Sethi G, and Kunnumakkara AB
- Subjects
- Humans, Antineoplastic Agents pharmacology, Antineoplastic Agents therapeutic use, Animals, Drug Synergism, ATP Binding Cassette Transporter, Subfamily B, Member 1 metabolism, Piper nigrum chemistry, Polyunsaturated Alkamides pharmacology, Benzodioxoles pharmacology, Benzodioxoles therapeutic use, Piperidines pharmacology, Piperidines therapeutic use, Alkaloids pharmacology, Neoplasms drug therapy, Neoplasms pathology, Drug Resistance, Neoplasm drug effects
- Abstract
Despite significant advancements in chemotherapy, effective treatments for advanced cancer stages remain largely elusive due to chemoresistance. Resistance to anticancer agents in cancer cells can arise through various mechanisms, including multi-drug resistance, inhibition of apoptosis, modification of drug targets, and enhancement of DNA repair capabilities. Consequently, there is a critical need for agents that can suppress the molecular signatures responsible for drug resistance. Piperine, an active alkaloid extracted from Piper nigrum L. (black pepper), is one such agent that has been extensively studied for its potential in addressing chronic diseases, including cancer. Piperine's antineoplastic properties are mediated through the regulation of numerous key cellular signaling pathways and the modulation of various biological processes. Its capability to enhance drug bioavailability and counteract mechanisms of drug resistance, such as the inhibition of P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP-1), emphasizes its potential as an adjunct in cancer therapy. Research across various cancer types has demonstrated piperine's role in chemosensitization by targeting P-gp and MRP-1 and altering drug-metabolizing enzymes. This review provides a comprehensive analysis of piperine's pharmacological characteristics and its capacity to modulate several cellular signaling pathways involved in drug resistance. Furthermore, the review emphasizes how piperine, when used in conjunction with other chemotherapeutic agents or natural compounds, can enhance therapeutic effects, leading to improved outcomes in cancer treatment., Competing Interests: Declaration of competing interest The authors claim no conflict of interest., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF